December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis? CME Congresses . December 23rd- PRECISION-T: Are We Entering a New Era of GVHD Prophylaxis? December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia CME Congresses . December 19th- BEYOND the Horizon: Long-Term Luspatercept Data in non–transfusion-dependent β-thalassemia December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence CME Congresses . December 18th- ASH 2025 Highlight: Stem Cell Boost for CAR-T–Related Hematologic Toxicity in multiple myeloma: Real-World Evidence December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update CME Congresses . December 16th- ASH 2025 Highlight- Menin Inhibitors AML Update December 12th- ASH 2025 Spotlight: BRUIN CLL-313 Pirtobrutinib Moves to the Frontline CME Congresses . December 12th- ASH 2025 Spotlight: BRUIN CLL-313 Pirtobrutinib Moves to the Frontline December 10th- ASH 2025 Spotlight: Sustained MRD as a Transformative Endpoint in Transplant-Ineligible Myeloma- Insights from the BENEFIT Phase 3 Study CME Congresses . December 10th- ASH 2025 Spotlight: Sustained MRD as a Transformative Endpoint in Transplant-Ineligible Myeloma- Insights from the BENEFIT Phase 3 Study December 9th- ASH 2025 Spotlight: inMMyCAR: First-in-Human In Vivo CAR-T for Relapsed/Refractory Myeloma CME Congresses . December 9th- ASH 2025 Spotlight: inMMyCAR: First-in-Human In Vivo CAR-T for Relapsed/Refractory Myeloma December 9th- ASH 2025 Spotlight: MajesTEC-3: A Landmark Phase 3 Trial in Relapsed/Refractory Myeloma CME Congresses . December 9th- ASH 2025 Spotlight: MajesTEC-3: A Landmark Phase 3 Trial in Relapsed/Refractory Myeloma December 9th- ASH 2025 Spotlight: Real-World Symptom Improvement With Belumosudil in Chronic GVHD CME Congresses . December 9th- ASH 2025 Spotlight: Real-World Symptom Improvement With Belumosudil in Chronic GVHD December 9th- ASH 2025 Spotlight: Response Dynamics to Belumosudil in Chronic GVHD CME Congresses . December 9th- ASH 2025 Spotlight: Response Dynamics to Belumosudil in Chronic GVHD Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18
